OncoMed Presents Data on Multiple Anti-Cancer Stem Cell Programs at … – Yahoo News
|
OncoMed Presents Data on Multiple Anti-Cancer Stem Cell Programs at …
Yahoo News OncoMed Pharmaceuticals, Inc. (Nasdaq: OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced data from an oral presentation and eight poster presentations at the … Alchemia Announces Presentation of Data on Its Discovery of a Potential New …SYS-CON Media (press release) |
